Interleukin-1 beta induced lewis X alteration in unexplained recurrent miscarriage [Poster abstract]

  • Problem Interleukin-1 beta (IL-1β) exhibits significant functions during implantation and placenta development, while increased level of IL-1β was observed in the endometrium as well as decidua of unexplained recurrent miscarriage (uRM) patients. Lewis X (LeX) is one of the commonest carbohydrate cell adhesion molecules that play pivotal roles in human embryogenesis and cell-cell interactions, it is also abundant at the endometrium during implantation stage. IL-1β has been reported to facilitate the upregulation of lewis antigens in many types of cancer cells. Currently there is no reports related to LeX expression in the decidua of uRM patients, and its potential linkage with aberrantly elevated IL-1β in the pathogenesis of uRM remains enigmatic. Method of Study Paraffin-embedded slides originating from placental tissue were collected from patients experiencing a miscarriage early in their pregnancy (6–13 weeks). Tissues collected from recurrent (RM, n = 15) miscarriages andProblem Interleukin-1 beta (IL-1β) exhibits significant functions during implantation and placenta development, while increased level of IL-1β was observed in the endometrium as well as decidua of unexplained recurrent miscarriage (uRM) patients. Lewis X (LeX) is one of the commonest carbohydrate cell adhesion molecules that play pivotal roles in human embryogenesis and cell-cell interactions, it is also abundant at the endometrium during implantation stage. IL-1β has been reported to facilitate the upregulation of lewis antigens in many types of cancer cells. Currently there is no reports related to LeX expression in the decidua of uRM patients, and its potential linkage with aberrantly elevated IL-1β in the pathogenesis of uRM remains enigmatic. Method of Study Paraffin-embedded slides originating from placental tissue were collected from patients experiencing a miscarriage early in their pregnancy (6–13 weeks). Tissues collected from recurrent (RM, n = 15) miscarriages and legally terminated normal pregnancies (NC, n = 10), considered as control group, were analyzed using immunohistochemical (IHC) staining. The expression of LeX and potentially associated glycosyltransferase genes FUT1/3/4 and ST3GAL3/4/6 in RL95-2 cells in response to IL-1β treatment were measured by flow cytometry, immunocytochemical staining, and real-time quantitative polymerase chain reaction (RT-qPCR). Results IHC staining revealed that LeX was mainly expressed in the luminal and glandular epithelium, FUTs and ST3GALs located in both stromal and epithelial cells. Expression of LeX, FUT3/4, and ST3GAL3/4 were significantly upregulated in RM group, while FUT1 was downregulated. ST3GAL6 showed no significant differences between groups. Treatment of RL95-2 cells with IL-1β induced significantly increased the expression of LeX. The transcript level of glycosyltransferase gene FUT3 was significantly elevated and that of FUT4 and ST3GAL3/4 were slightly suppressed by the treatment. Conclusions LeX and pertinent glycosyltransferase genes FUT1/3/4 and ST3GAL3/4 are notably dysregulated in the decidua of uRM patients. Aberrantly elevated IL-1β in uRM may facilitate the inappropriate implantation through enhancing the expression of LeX and FUT3.show moreshow less

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Zhi Ma, Sven Mahner, Udo JeschkeORCiDGND, Viktoria von Schönfeldt
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/107829
ISSN:0165-0378OPAC
Parent Title (English):Journal of Reproductive Immunology
Publisher:Elsevier BV
Type:Article
Language:English
Date of first Publication:2023/08/30
Release Date:2023/09/20
Tag:Obstetrics and Gynecology; Reproductive Medicine; Immunology; Immunology and Allergy
Volume:158
First Page:103598
DOI:https://doi.org/10.1016/j.jri.2022.103598
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Frauenheilkunde